TGRO, OLIE, PROW, ARIA & Extended Watchlist

Tiger Oil & Energy, Inc.  TGRO

We’ve been following TGRO since Monday of last week, at which time the stock was trading as low .36. After running up to the low .60’s, we observed the stock pull back to .38. We were encouraged to find that it held support above our initial alert low, as higher lows following a pullback are often a good sign.

Sure enough, since then, the stock has been stair-stepping its way up to hit yesterday’s high of .75. That marks a 108% overall move from our initial alert price, and up to 97% from TGRO’s most recent low of .38.


Olie, Inc. OLIE

On Wednesday, OLIE was an excellently timed call for us. We had the opportunity to make up to 147% profit as the stock ran from .0082-.02 before pulling back significantly to close at .0097.

Following up in yesterday’s report, we stated: “…with the kind of volatility we’re seeing out of OLIE, we definitely want to pay attention heading into week’s end. Further opportunities could certainly present themselves.” Our call turned out to be spot-on once again.

The stock shot right out of the gate to make a rapid 55% move from .0097 to .015. Then, following a pullback to .0108, it ran again, this time to .016, a 48% spike.

That brought our two-day total cumulative gains on OLIE to an impressive 250%


Progress Watch Corp. PROW

PROW popped up on our abnormal activity scanner yesterday, and we had to make certain to pass it along today.

Chart conditions appear to be favorable: The RSI is ready to breach into the power zone, and the MACD recently experienced a bullish cross. The 50DMA is rising sharply toward the 200DMA that should lead to a golden cross in the week and months ahead. Presently, we’re looking to see PROW push through and hold support above its 200DMA at  .0072.

We also want to point out that PROW boasts an extremely tight share structure, with only 25.1 million in the float as of March of this year. A stock trading at this increment with such a low float needs only a relatively small amount of buying pressure to produce significant gains.


ARIAD Pharmaceuticals, Inc. ARIA

We’ve been tracking ARIA ever since November 26th. Since that time, we’ve observed the stock trading as low as 3.80. ARIA has been picking up steam over the past few sessions, posting higher highs and higher lows for three consecutive days.

Yesterday it hit a high of 5.58, marking an increase of 47% over recent lows.


Extended Watchlist:
PLPE (Gapping Down on Large Premarket Volume), AMRN, ORMP, TSEM, CLWT, CYTR, BCRX,

ICNB, AMRN, AKS & Today’s Extended Watchlist

We try to bring you a nice selection of quality picks on a daily basis, and believe us, we are well aware of our competition. There simply isn’t another stock newsletter out there that has our level of continual success, coupled with concern for our readers’ success. Anywhere.

____

Iconic Brands, Inc. ICNB

Take ICNB for instance. We put this forth yesterday as a momentum play, and after touching a low of .022, the stock surged ahead, closing at .055. Total possible single-session gains: 150%

____

Amarin Corp. Plc AMRN

Despite receiving FDA approval for their new drug, AMRN appears to be gapping down this morning. After all of the hype and baked-in PPS leading into the approval date, it appears the stock now wants consolidate. Excessive profit-taking in these instances can hold back the progress of a stock, so we will be observing for any possible bounces.

BEDMINSTER, N.J. and DUBLIN, Ireland, July 26, 2012 (GLOBE NEWSWIRE) — Amarin Corporation plc (Nasdaq:AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, announced today that the U.S. Food and Drug Administration (FDA) has approved Vascepa(TM) (icosapent ethyl) capsules (formerly known as AMR101) as an adjunct to diet to reduce triglyceride (TG) levels in adult patients with severe (TG greater than or equal to 500mg/dL) hypertriglyceridemia (very high triglycerides).

____

AK Steel Holding Corp. AKS  &  Arch Coal, Inc. ACI

On June 18th, we alerted ACI as a bottom-fishers dream, and the stock subsequently ran from a low of 5.41 to 7.63 for a gain of 41% The stock saw a new low yesterday (5.16), and again seems like a good one to watch for a possible upcoming bounce.

AKS is exhibiting some similar characteristics to ACI. The charts are alike in many ways, and like ACI, AKS is hovering around a bottom. Therefore, we want to keep an eye on it moving forward, in the event that it matches the kind of bounce we saw in ACI.

____

Extended Watchlist:

IMDS, AAPT, RENU, BBDA, STEM, NOK

IDOI, HAIR & Today’s Extended Watchlist

IDO Security, Inc. IDOI

IDOI has been on fire of late, doubling in value over the past three trading sessions, with four consecutive green days in a row.

Normally at this point, we would consider taking profits off of the table, however, we feel that there is still potential for added gains here. In instances such as this, when our money has doubled yet strength remains, we are likely to sell half of our position, and play the rest with the house’s money.

BARCHART.com is still currently giving IDOI a 72% Overall Buy Rating

____

Biostem U.S. Corp HAIR

After a recent 597% run from the .06 area to .46, HAIR has consolidated, and been making higher lows off of support in the low .20’s.

Just in the past week, the stock got above the 20 & 50 day moving averages, leading us to believe that another run is in the making.

There are also several indicators on the chart which suggest that HAIR has some real potential for growth (no pun intended!).

____

FDA PLAYS — AMRN, HZNP, TLON

HZNP has appeared in our watchlist recently. Yesterday, the stock was up 7%, and appears as if it may gap up this morning. With the company’s FDA PDUFA date approaching on Friday, we certainly want to keep a close watch over HZNP in the next few sessions.

AMRN’s FDA date is this Thursday, one day prior to HZNP’s. We are watching closely here as well.

TLON’s date is coming up in a couple weeks (08/12/12), so there isn’t as much of a sense of urgency just yet, but we will still be following along as zero-hour approaches.

____

Extended Watchlist:

EGCT, STEM, RENU, IWDM